4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-24-041418
Chief Legal Officer sold 8,153 shares at $31.78 ($259,102)
- Chief Legal Officer acquired 8,153 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bizily Scott Chief Legal Officer | 2024-04-01 | Option exercise 10b5-1 | +1,332 | $6.49 | $8,645 | 3,069 | D |
| Bizily Scott Chief Legal Officer | 2024-04-01 | Option exercise 10b5-1 | +2,916 | $8.04 | $23,445 | 5,985 | D |
| Bizily Scott Chief Legal Officer | 2024-04-01 | Option exercise 10b5-1 | +1,996 | $15.78 | $31,497 | 7,981 | D |
| Bizily Scott Chief Legal Officer | 2024-04-01 | Option exercise 10b5-1 | +1,909 | $20.24 | $38,638 | 9,890 | D |
| Bizily Scott Chief Legal Officer | 2024-04-01 | Sale 10b5-1 | −8,153 | $31.78 | $259,102 | 1,737 | D |
| Derivatives | |||||||
| Bizily Scott Chief Legal Officer | 2024-04-01 | Option exercise · Stock Option (Right To Buy) 10b5-1 | −1,332 | 14,711 | D | ||
| Bizily Scott Chief Legal Officer | 2024-04-01 | Option exercise · Stock Option (Right To Buy) 10b5-1 | −2,916 | 40,418 | D | ||
| Bizily Scott Chief Legal Officer | 2024-04-01 | Option exercise · Stock Option (Right To Buy) 10b5-1 | −1,996 | 21,008 | D | ||
| Bizily Scott Chief Legal Officer | 2024-04-01 | Option exercise · Stock Option (Right To Buy) 10b5-1 | −1,909 | 46,182 | D | ||
| Open-market sales · 8,153 sh · avg $31.78 · $259,102 | |||||||
Loading xslF345X05/ownership.xml…